Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/3222
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOlapade-Olaopa, E.O-
dc.contributor.authorOgunbiyi, J.O-
dc.contributor.authorMuronda, C.A-
dc.contributor.authorOkeke, L.I-
dc.contributor.authorShittu, O.B-
dc.contributor.authorDanso, A.P-
dc.date.accessioned2025-01-14T11:52:56Z-
dc.date.available2025-01-14T11:52:56Z-
dc.date.issued2007-
dc.identifier.citationAfr J Med Med Sci 2007, 36(4):311-316en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/3222-
dc.descriptionArticleen_US
dc.description.abstractProstatic specific antigen (PSA) immunoreactivity is the most commonly used histological marker to identity epithelial cells of prostate origin. Unlike tissues from white men in which grade-related variability has been reported, the pattern of PSA immunoreactivity in prostatic tissues from black African men is presently unknown. This study was done to evaluate the pattern of PSA staining in sections of normal, benign hyperplastic and malignant prostatic glands from men from this sub-population. PSA immunostaining was done on 4-fim serial sections from archival specimens of benign prostatic hyperplasia (BPH) and carcinoma of the prostate (CaP) obtained from black Africa n men using standard immunoperoxidase techniques. The intensity of PSA immunoreactivity of the glands was scored using a semi-quantitative method. PSA expression decreased with increasing de-differentiation of the tissue histotype with poorly differentiated tumours staining least. PSA immunoreactivity was strong in 100% of normal glands and 84% of BPH glands and moderate in the rest. In contrast, PSA immunoposilivity was strong in 32% of CaP glands, moderate in 26% weak in 34% and absent in 8%. Statistical comparison revealed that PSA expression was significantly higher in benign tissues (normal/ atrophic and BPH) than in CaP glands [p=<0.0001]. Our findings show that PSA immunoreactivity is grade-related in prostatic tissues from black men and this has implications for clinical diagnosis and research. It also confirms the limitations of PSA-testing in diagnosing CaP, and indicates that newer immunohistochemical tests for malignant prostatic cells should be acquired by Sub-Saharan laboratories.en_US
dc.description.sponsorshipCOLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, NIGERIAen_US
dc.language.isoenen_US
dc.publisherCOLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, NIGERIAen_US
dc.subjectPSA immunoreactivityen_US
dc.subjectprostateen_US
dc.subjectBPHen_US
dc.subjectprostate canceren_US
dc.subjectblack Africanen_US
dc.subjectimmunohistochemistryen_US
dc.titleAnti-PSA immunoreactivity in primar y prostatic tissues from Black African menen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Olapade-Olaopa et al_Anti-PSA_2007.pdfArticle14.14 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.